USPTO serial 98423222
ORIGEN BIOMEDICAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 25, 2025
- Examiner
- KEAN, AMY C
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ORIGEN BIOMEDICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julia Spoor Gard
Julia Spoor Gard Barnes & Thornburg LLP11 South Meridian StreetIndianapolis, IN 46204United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Cell cryopreservation solutions, namely, dimethyl sulfoxide solution for clinical and research use | ACTIVE | Aug 10, 2012 |
| 010 | Specialized containers for medical use all sold empty, namely, blood and stem cell storage bags, single-use disposable containers for biological and pharmaceutical materials, and empty plastic bags tailored for the storage of blood and stem cells, all for medical purposes; medical use containers for the transportation, and containment of bioprocessing materials, all sold empty and designed for single-use; medical containers for the processing, handling, storage, and transport of sterile fluids for medical use, namely, bio-containers optimized for ultra-low temperature use, all sold empty; cell culture containers specifically designed for medical use sold empty | ACTIVE | Aug 10, 2012 |
| 040 | Custom manufacture of medical devices, namely single-use disposable cryopreservation and cell culture products, including bags, accessories, and cryoprotectant solutions for the regenerative medicine, biotechnology, and pharmaceutical fields | ACTIVE | Aug 10, 2012 |
| 042 | Custom design and development of medical devices, namely single-use disposable cryopreservation and cell culture products, including bags, accessories, and cryoprotectant solutions for the regenerative medicine, biotechnology, and pharmaceutical fields | ACTIVE | Aug 10, 2012 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OriGen Biomedical, Inc.
- Other trademarks owned by OriGen Biomedical, Inc.
- Other trademarks owned by OriGen Biomedical, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named ORIGEN BIOMEDICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 25, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 25, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 7, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 7, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 1, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 13, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 12, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 12, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 12, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 16, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 15, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 8, 2024 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 8, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 27, 2024 | NWAP | NEW APPLICATION ENTERED | — |